Over the past week,
McKesson Corp (NYSE:MCK) has exhibited strong market performance, even reaching a
52-week high. Despite frequent
underperformance on some trading days, overall positive momentum is evident. The company is largely controlled by
institutional shareholders, owning 88% of the company, giving it a secure investment base. There is speculation about an overvaluation of the company, however, its
intrinsic value is potentially 82% higher than its current share price. In their Q4 2024 earnings call, McKesson reported mixed results with revenue growth but adjusted EPS inconsistencies. Despite an earnings dip, the company posted strong revenue growth and raised their full-year guidance. Significant insider trading was reported, including EVP & Chief HR Officer, Leann Smith, and CEO, Brian S Tyler selling substantial shares. McKesson earned recognition as a strong
value stock and a strong
momentum stock for the long-term. The company declared its Q4 earnings and is reportedly set to sell the Canadian Rexall Pharmacy Group.
Mckesson Corporation MCK News Analytics from Tue, 17 Oct 2023 07:00:00 GMT to Sun, 09 Jun 2024 14:19:06 GMT -
Rating 6
- Innovation -5
- Information 7
- Rumor -1
